Sitemap
Blog
07/01/2020 - IL1RAP, a new biomarker of interest for cancer targeting 06/26/2020 - An introduction to the Exosome world 06/23/2020 - Revealing the full potential of Adeno Associated Virus thanks to molecular biology 06/09/2020 - How much do you know about COVID-19 proteins? 06/02/2020 - Immediate Discount on SYnAbs COVID-19 products 05/25/2020 - Patients’ Immune Battle Against COVID-19 05/05/2020 - Latest News on COVID-19 04/03/2020 - Immune Response to Coronavirus infection 03/31/2020 - 11 Strategies To Treat Coronavirus You Should Know 03/17/2020 - Bispecific Antibody: The Janus God Of Therapeutics? 03/02/2020 - Top Facts You Don't Know About Rat Monoclonals 02/25/2020 - The Future Of Therapeutic Antibodies Development 02/19/2020 - More human than human is our motto 02/14/2020 - "Anta", "Block", "Neutra"...but Who Are They? 02/10/2020 - In Gut We Trust 02/04/2020 - Not One Monoclonal But Two mAbs can detect ANY PROTEIN! 01/30/2020 - The Dark Side Of CAR-T Therapy 01/16/2020 - In accordance with FDA, can a biotinylated mAb be replaced by a DNP marked mAb? 01/14/2020 - Time to meet SYnAbs in Dubai! 12/05/2019 - LO-HG4 Anti-human IgG4 monoclonal antibody 11/25/2019 - Hybridoma VS Display : The Fight Of The Century 11/14/2019 - Mycotoxins: the reign of terror 10/29/2019 - Smaltis & mAbexperts partnership 10/25/2019 - mAbexperts. What is it? How it works? 10/23/2019 - What is the Kd of your antibody? 10/18/2019 - Are you sure you know everything about the Rat? 10/02/2019 - The enigmatic subclass antibody, new SYngular products from SYnAbs 09/25/2019 - Three Letters You Should Be Aware Of 09/18/2019 - Answers to frequently asked questions on secondary antibodies 09/18/2019 - New logo for mAbexperts group 09/16/2019 - Your DNA isn't your destiny: news on epigenetics 08/07/2019 - SYnAbs enters in India! 07/04/2019 - Happy independence day to all our US friends on the behalf of SYnAbs team! 07/02/2019 - mAbexperts commits to the future of immunotherapy: Complete VHH-CAR-T design 06/26/2019 - Best tips to select an outsourcing provider for custom antibody generation 06/25/2019 - SYnAbs attended Pivotal Scientific congress in Oxford 06/10/2019 - Innovative anti-VHH antibodies : SYnAbs enters the nano-world 06/08/2019 - Innovative tools to boost your research on infectious diseases 05/20/2019 - SYnAbs in United Kingdom for antibody generation 05/15/2019 - mAbexperts attends Buzz4Bio outsourcing congress 05/08/2019 - SYnAbs at Knowledge For Growth 04/29/2019 - SYnAbs attends K4G on May 9th 04/27/2019 - The CAM family: a new target for monitoring or treating cancers? 04/25/2019 - SYnAbs attends Biotechnica Labvolution congress 04/20/2019 - SYnAbs and Univercells announce service agreement on biosimilar 04/19/2019 - Meet mAb Experts at AIS Congress 04/16/2019 - Why DNA immunization is still necessary? 04/12/2019 - Replacing in-vivo by an in-vitro test? Rabies mAb example 03/23/2019 - SYnAbs recherche de nouveaux talents 03/11/2019 - Neurogenic and SYnAbs deal for schizophrenia detection 02/05/2019 - mAb Experts attends Buzz4Bio congress in France 01/28/2019 - Horiba & SYnAbs partnership : Production of guinea pig monoclonal antibody directed against a steroid hormone and its binding study thanks to SPRi technology 01/15/2019 - ZenTech and SYnAbs sign strategic partnership agreement to generate innovative monoclonal antibodies targeting 8 hemoglobinopathia diseases 01/11/2019 - Happy New Year 2019! 11/28/2018 - SYnAbs: the launch of 3 innovative rat mAbs 11/14/2018 - SYnAbs is attending Medica congress 10/31/2018 - SYnAbs is at AusBiotech congress looking for Australian distributors 10/01/2018 - SYnAbs enters in Italy! 08/28/2018 - SYnAbs is proud to announce ISO 9001:2015 certification! 08/04/2018 - SYnAbs attended AACC congress in Chicago! Great success! 07/27/2018 - SYnAbs enters Chinese market! 06/25/2018 - SYnAbs is looking for new talents to expand its cell culture team 06/19/2018 - SYnAbs attended Pivotal Congress in Oxford 02/06/2018 - SYnAbs attended Buzz4Bio Cell&Gene Therapies 02/01/2018 - SYnAbs attended Innovation for Health in Rotterdam 01/24/2018 - SYnAbs launches mouse isotyping kit, MYstik™ 01/24/2018 - SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco 01/17/2018 - SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël 12/14/2017 - SYnAbs/RD Biotech unique expertise in CAR-T cells 11/27/2017 - SynAbs, from UCL benches to Singapore 11/20/2017 - SynAbs attended Medica congress in Dusseldorf, Germany 10/24/2017 - SynAbs inks first distribution agreement in Asia 09/05/2017 - SynAbs widens its team to sustain organic growth 06/21/2017 - SynAbs attended Pivotal Scientific congress in Oxford! 06/01/2017 - SynAbs moves its facilities to Gosselies BioPark 05/24/2017 - SynAbs attended BioMed congress in Israël! 05/18/2017 - SynAbs attended Knowledge for Growth event in Ghent! 05/10/2017 - SynAbs attended WBC 10th anniversary as special guest! 05/05/2017 - SynAbs inks agreement with Sapphire as new distributor for its unique catalogue of monoclonal antibodies in USA & Canada 01/13/2017 - SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany 09/19/2016 - SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland 08/03/2016 - Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics 08/03/2016 - The small molecule detection challenge : the aflatoxin case study 01/28/2016 - SynAbs brings rats to antibody market 09/01/2015 - SynAbs set-up, a new rat mAb expert on the marketplace
This website uses cookies.
This website uses cookies to give you the best online experience. Please let us know if you agree by clicking on the “Accept” option below. If you’d like to find out more about the cookies we use and set your individual cookie preferences, please review our Cookie Policy. More details here: Cookie Policy
